Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.05 AUD | -2.97% | +6.74% | +49.31% |
03:36am | Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50 | MT |
Apr. 18 | Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 from AU$13.27, Keeps at Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.31% | 3.36B | |
+0.29% | 42.86B | |
+11.85% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.50% | 25.15B | |
-24.01% | 18.63B | |
+27.64% | 12.37B | |
-3.84% | 11.92B | |
+7.24% | 11.21B |
- Stock Market
- Equities
- TLX Stock
- News Telix Pharmaceuticals Limited
- Telix Pharmaceuticals Logs Nearly $115 Million Revenue in Q1